Related Experiment Video
Updated: May 31, 2026

15:27
Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
Published on: April 17, 2017
Comparison of four distinct detection platforms using multiple ligand binding assay formats
Catherine I Soderstrom1, Franklin P Spriggs, Wei Song
1Pfizer, Inc, 558 Eastern Point Road Groton, CT 06340, United States.
Journal of Immunological Methods
|July 14, 2011
Summary
Comparing ligand binding assay (LBA) detection platforms reveals no single best option. Testing multiple platforms like colorimetric, chemiluminescence, TRF, and ECL is crucial for optimal biotherapeutic agent detection.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Assay Development
Background:
- Ligand binding assays (LBA) are vital for biotherapeutic quantitation.
- Various detection platforms exist, but direct comparisons for interchangeability are scarce.
- Claims of superior sensitivity and dynamic range among platforms lack comprehensive validation.
Purpose of the Study:
- To evaluate and compare the interchangeability of four common LBA detection platforms.
- To assess sensitivity and dynamic range across different LBA formats.
- To provide data-driven insights for selecting optimal detection platforms.
Main Methods:
- Compared colorimetric, chemiluminescence, time-resolved fluorescence (TRF), and electrochemiluminescence (ECL) detection platforms.
- Utilized five distinct LBA protocols: direct binding, sandwich ELISA, competitive, and cell-based ELISA.
- Evaluated sensitivity and dynamic range for each platform-assay combination.
Main Results:
- No single detection platform consistently outperformed others across all tested LBA protocols.
- Predicting the best-performing platform for a specific assay protocol was not feasible.
- Observed significant assay-specific differences, including plate coating efficiency and low signal issues, complicating platform selection.
Conclusions:
- The selection of a detection platform for LBAs is highly assay-dependent.
- Developing new LBA protocols requires testing multiple detection platforms to ensure optimal performance.
- This comparative study highlights the need for empirical validation rather than relying on general platform claims.
